​

Funding Round

Series A - VenoStent

Series A - VenoStent

Investment Firm

Overview

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

Announced Date

Jun 27, 2024

Closed on Date

Jun 27, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Norwest Venture Partners

Norwest Venture Partners

Norwest Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and private_equity and secondary_market and venture firm.

Participant Investors

2

Investor Name
Participant InvestorIAG Capital Partners
Participant InvestorNorwest Venture Partners

Round Details and Background

VenoStent raised $4000000 on 2024-06-27 in Series A

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 31, 2023
Series A - VenoStent
8-16.0M
Sep 22, 2017
Seed Round - VenoStent
1-30.0K
Jun 27, 2024
Series A - VenoStent
3-4.0M
Jun 27, 2024
Grant - VenoStent
1-3.6M

Recent Activity

There is no recent news or activity for this profile.